Van Hulzen Asset Management LLC Purchases 11,532 Shares of Danaher Corporation $DHR

Van Hulzen Asset Management LLC raised its position in Danaher Corporation (NYSE:DHR) by 11.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 114,005 shares of the conglomerate’s stock after buying an additional 11,532 shares during the quarter. Danaher comprises about 1.9% of Van Hulzen Asset Management LLC’s portfolio, making the stock its 11th largest position. Van Hulzen Asset Management LLC’s holdings in Danaher were worth $26,098,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. JPL Wealth Management LLC bought a new stake in shares of Danaher during the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter worth approximately $26,000. WFA of San Diego LLC bought a new stake in shares of Danaher during the 2nd quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher during the 3rd quarter worth approximately $27,000. Finally, Financial Life Planners bought a new stake in shares of Danaher during the 3rd quarter worth approximately $32,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Morgan Stanley decreased their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Jefferies Financial Group reiterated a “buy” rating and issued a $245.00 price target on shares of Danaher in a research note on Tuesday, April 21st. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Finally, The Goldman Sachs Group decreased their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Nineteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $238.65.

Danaher Trading Up 1.4%

Shares of DHR opened at $173.51 on Friday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The business’s fifty day moving average is $183.98 and its 200-day moving average is $208.99. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The firm has a market cap of $122.80 billion, a price-to-earnings ratio of 33.56, a PEG ratio of 2.29 and a beta of 0.81.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter last year, the company posted $1.88 EPS. Equities analysts anticipate that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s payout ratio is currently 30.95%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.